Paysign (NASDAQ:PAYS – Get Free Report) announced its earnings results on Wednesday. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.05, FiscalAI reports. The company had revenue of $28.25 million during the quarter, compared to analyst estimates of $26.36 million. Paysign had a net margin of 15.67% and a return on equity of 31.70%. Paysign updated its FY 2026 guidance to 0.350-0.370 EPS and its Q3 2026 guidance to 0.090-0.100 EPS.
Here are the key takeaways from Paysign’s conference call:
- Record second-quarter results included revenue of $28.3 million, up 48% year over year, net income of $6.8 million, and adjusted EBITDA of $9.6 million, up 113%; gross margin expanded to 63.3%.
- Patient Affordability remained the primary growth engine, with revenue rising 89% to $14.6 million, claims increasing approximately 54%, and active programs reaching 148, up from 97 a year ago. Management expects to match or exceed 55 net program additions in 2026 and sees a substantial addressable market.
- The plasma business showed recovery, with revenue up 21.4% to $13 million and monthly revenue per center reaching $7,699, its highest level since the third quarter of 2024. Management said the prior inventory overhang has largely normalized, although the center count declined to 561 after closures.
- Paysign raised its full-year 2026 outlook to revenue of $114 million-$117 million, gross margin of 62%-63%, GAAP net income of $21.5 million-$23 million, and adjusted EBITDA of $35 million-$38 million. The company ended the quarter with $27.4 million in unrestricted cash and no bank debt.
- Management expects fourth-quarter profitability to be weaker than the third quarter because of seasonal mix, holiday-related software capitalization effects, higher expected taxes, and planned hiring to support continued Patient Affordability growth. Full-year GAAP earnings also include a one-time, non-cash $990,000 benefit tied to the Gamma acquisition earn-out liability.
Paysign Stock Performance
Shares of NASDAQ:PAYS traded down $0.26 during trading hours on Friday, reaching $12.14. The stock had a trading volume of 484,687 shares, compared to its average volume of 693,161. The firm’s 50 day moving average is $8.20 and its 200-day moving average is $6.06. The stock has a market capitalization of $678.75 million, a price-to-earnings ratio of 46.69 and a beta of 0.74. Paysign has a 1 year low of $3.08 and a 1 year high of $12.85.
Insider Activity
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in PAYS. Goldman Sachs Group Inc. raised its stake in Paysign by 7.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 258,334 shares of the company’s stock valued at $548,000 after acquiring an additional 17,466 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of Paysign during the first quarter worth $51,000. Rhumbline Advisers lifted its holdings in shares of Paysign by 5.2% during the first quarter. Rhumbline Advisers now owns 46,587 shares of the company’s stock worth $99,000 after purchasing an additional 2,303 shares during the period. Geode Capital Management LLC grew its position in Paysign by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 788,500 shares of the company’s stock valued at $5,679,000 after buying an additional 12,490 shares during the last quarter. Finally, Invesco Ltd. increased its stake in Paysign by 19.1% in the 2nd quarter. Invesco Ltd. now owns 16,942 shares of the company’s stock valued at $122,000 after buying an additional 2,716 shares during the period. Institutional investors and hedge funds own 25.89% of the company’s stock.
Wall Street Analyst Weigh In
PAYS has been the subject of a number of research analyst reports. Barrington Research set a $11.00 target price on Paysign in a report on Monday. DA Davidson raised their price objective on shares of Paysign from $9.00 to $12.00 and gave the company a “buy” rating in a research note on Thursday. Lake Street Capital restated a “buy” rating and issued a $13.00 price objective on shares of Paysign in a report on Thursday. Wall Street Zen downgraded shares of Paysign from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 13th. Finally, Weiss Ratings raised shares of Paysign from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, Paysign currently has a consensus rating of “Buy” and a consensus target price of $12.00.
Get Our Latest Report on Paysign
Paysign Company Profile
Paysign, Inc (NASDAQ:PAYS) is a U.S.-based financial technology company specializing in prepaid payment solutions. Through its cloud-based platform, the company enables corporations, government agencies and payroll providers to issue and manage stored-value cards, digital wallets and disbursement programs. Paysign’s offerings span gift and incentive cards, payroll and earned-wage access cards, government benefit distribution, tax refund solutions and health savings account disbursements.
The company’s flagship Paysign Experience Platform provides configurable card programs with real-time transaction reporting, fraud monitoring and regulatory compliance tools.
Read More
- Five stocks we like better than Paysign
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
